• Summary of FDA Advertising and Promotion Enforcement Activities - June 2011
  • August 4, 2011 | Authors: Scott Cunningham; Scott D. Danzis; Michael S. Labson; Erika Lietzan
  • Law Firm: Covington & Burling LLP - Washington Office
  • This e-alert is part of a monthly series of e-alerts summarizing publicly-available FDA enforcement letters (i.e., warning letters and untitled letters) relating to the advertising and promotion of drugs, biologics, and medical devices. In June 2011, FDA’s Division of Drug Marketing, Advertising, and Communications (DDMAC) posted the following three enforcement letters on its website: